Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Population Health Research Institute
With
Abbott Medical Devices
Hamilton Health Sciences Corporation
Age
19–84
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\> 18 and \< 85 years of age
ICD implanted for primary prophylaxis against sudden cardiac death or ICD implanted for secondary prophylaxis against spontaneous or inducible sustained VT without any reversible causes
Coronary artery disease (CAD) with prior myocardial infarction (MI)
ICD or electrocardiogram (ECG) documentation of ventricular arrhythmia responsible for appropriate ICD therapy \[antitachycardia pacing (ATP) \& shocks\].
You may not be if
Contraindication or allergy to contrast media, routine procedural medications or catheter materials
Contraindication to an interventional procedure
Current or previous (within 3 months) amiodarone therapy
Atrial Fibrillation requiring antiarrhythmic drug therapy
Contraindication to amiodarone therapy
New York Heart Association (NYHA) functional class IV
Myocardial infarction within the past 60 days
Stroke within the past 90 days
Unstable angina
Hypertrophic cardiomyopathy, Non-ischemic dilated cardiomyopathy, Arrhythmogenic Right Ventricular Dysplasia, Brugada Syndrome, Catecholamine sensitive polymorphic VT or long QT syndrome
Patients with active ischemia that are eligible for revascularization
Life expectancy less than 6 months
Incessant or multiple episodes of VT requiring immediate therapy with medications or ablation
Untreated hypothyroidism or hyperthyroidism. Patients who are euthyroid on thyroid hormone replacement therapy are acceptable.
Current enrollment in another investigational drug or device study.
Presence of any other condition that the investigator feels would be problematic or would restrict or limit the participation of the patient for the entire study period.
Absolute contra-indication to the use of heparin and or warfarin.
Documented intra-atrial thrombus, ventricular thrombus (\< 6 months after detection of thrombus), tumor, or another abnormality which precludes catheter introduction.
Females of childbearing potential who are not practicing protocol acceptable method of birth control.
